123 related articles for article (PubMed ID: 7963545)
21. Highly restricted TCR-alpha beta usage by autoreactive human T cell clones specific for DNA topoisomerase I: recognition of an immunodominant epitope.
Kuwana M; Medsger TA; Wright TM
J Immunol; 1997 Jan; 158(1):485-91. PubMed ID: 8977226
[TBL] [Abstract][Full Text] [Related]
22. TCR reactivity in human nickel allergy indicates contacts with complementarity-determining region 3 but excludes superantigen-like recognition.
Vollmer J; Weltzien HU; Moulon C
J Immunol; 1999 Sep; 163(5):2723-31. PubMed ID: 10453014
[TBL] [Abstract][Full Text] [Related]
23. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
[TBL] [Abstract][Full Text] [Related]
24. Evidence for preferential T cell receptor V beta gene usage and T cell clonal expansion in the synovium of BB rats with early-onset collagen-induced arthritis.
Ye XJ; Aelion J; Endres RO; Kang AH; Cremer MA
Cell Immunol; 1998 Feb; 183(2):81-9. PubMed ID: 9606991
[TBL] [Abstract][Full Text] [Related]
25. Usage of T cell receptor beta-chain variable gene is highly restricted at the site of inflammation in murine autoimmune uveitis.
Rao NA; Naidu YM; Bell R; Lindsey JW; Pararajasegaram G; Sun Y; Steinman L
J Immunol; 1993 Jun; 150(12):5716-21. PubMed ID: 8390540
[TBL] [Abstract][Full Text] [Related]
26. Local-clonal expansion of infiltrating T lymphocytes in chronic encephalitis of Rasmussen.
Li Y; Uccelli A; Laxer KD; Jeong MC; Vinters HV; Tourtellotte WW; Hauser SL; Oksenberg JR
J Immunol; 1997 Feb; 158(3):1428-37. PubMed ID: 9013988
[TBL] [Abstract][Full Text] [Related]
27. Nonrandom T cell receptor usage in the allorecognition of HLA-DR1 microvariation.
Hurley CK; Steiner N; Wagner A; Geiger MJ; Eckels DD; Rosen-Bronson S
J Immunol; 1993 Feb; 150(4):1314-24. PubMed ID: 8381833
[TBL] [Abstract][Full Text] [Related]
28. T cell receptor alpha-chain repertoire of pathogenic autoantibody-inducing T cells in lupus mice.
Mao C; Osman GE; Adams S; Datta SK
J Immunol; 1994 Feb; 152(3):1462-70. PubMed ID: 8301146
[TBL] [Abstract][Full Text] [Related]
29. TCR beta PCR from crude preparations for restriction digest or sequencing.
Clark LS; Nicklas JA
Environ Mol Mutagen; 1996; 27(1):34-8. PubMed ID: 8625946
[TBL] [Abstract][Full Text] [Related]
30. A single cell analysis of TCR AV24AJ18+ DN T cells.
Keino H; Matsumoto I; Okada S; Kurokawa M; Kato T; Tokuhisa T; Usui M; Taniguchi M; Nishioka K; Sumida T
Microbiol Immunol; 1999; 43(6):577-84. PubMed ID: 10480554
[TBL] [Abstract][Full Text] [Related]
31. T cell receptor BV gene rearrangements in the spinal cords and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Panzara MA; Gussoni E; Begovich AB; Murray RS; Zang YQ; Appel SH; Steinman L; Zhang J
Neurobiol Dis; 1999 Oct; 6(5):392-405. PubMed ID: 10527806
[TBL] [Abstract][Full Text] [Related]
32. Dominant T cell receptor rearrangements in interleukin 2 expanded lymphocytes from rheumatoid nodules suggest antigen driven T cell activation in situ.
De Keyser F; Elewaut D; Overmeer-Graus JP; Van den Broek P; Rijnders AW; Veys EM
J Rheumatol; 1997 Sep; 24(9):1685-9. PubMed ID: 9292788
[TBL] [Abstract][Full Text] [Related]
33. Expression of the putative Duchenne muscular dystrophy gene in differentiated myogenic cell cultures and in the brain.
Nudel U; Robzyk K; Yaffe D
Nature; 1988 Feb; 331(6157):635-8. PubMed ID: 3340214
[TBL] [Abstract][Full Text] [Related]
34. Duchenne muscular dystrophy gene product is not identical in muscle and brain.
Nudel U; Zuk D; Einat P; Zeelon E; Levy Z; Neuman S; Yaffe D
Nature; 1989 Jan; 337(6202):76-8. PubMed ID: 2909892
[TBL] [Abstract][Full Text] [Related]
35. [Ultrasound imaging of muscles in Duchenne muscular dystrophy].
Aizawa H; Kozima S; Takagi A
Rinsho Shinkeigaku; 1989 Jan; 29(1):49-53. PubMed ID: 2663295
[TBL] [Abstract][Full Text] [Related]
36. Alterations in creatine kinase in fresh muscle and cell cultures in Duchenne dystrophy.
Ionasescu V; Ionasescu R; Feld R; Witte D; Cancilla P; Kaeding L; Stern LZ
Ann Neurol; 1981 Apr; 9(4):394-9. PubMed ID: 7224603
[TBL] [Abstract][Full Text] [Related]
37. Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine.
Bernasconi P; Torchiana E; Confalonieri P; Brugnoni R; Barresi R; Mora M; Cornelio F; Morandi L; Mantegazza R
J Clin Invest; 1995 Aug; 96(2):1137-44. PubMed ID: 7635950
[TBL] [Abstract][Full Text] [Related]
38. Element analysis of skeletal muscle in Duchenne muscular dystrophy using x-ray fluorescence spectrometry.
Maunder-Sewry CA; Gorodetsky R; Yarom R; Dubowitz V
Muscle Nerve; 1980; 3(6):502-8. PubMed ID: 7453715
[TBL] [Abstract][Full Text] [Related]
39. A quantitative comparison of satellite cell ultrastructure in Duchenne muscular dystrophy, polymyositis, and normal controls.
Watkins SC; Cullen MJ
Muscle Nerve; 1986 Oct; 9(8):724-30. PubMed ID: 3785283
[TBL] [Abstract][Full Text] [Related]
40. Nucleotide and corresponding amino acid sequence of human adult and fetal cDNA coding for portions of the Duchenne muscular dystrophy (DMD) gene.
Rosenthal A; Speer A; Billwitz H; Cross GS; Forrest SM; Davies KE
Biomed Biochim Acta; 1988; 47(2):K13-5. PubMed ID: 3178779
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
